| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2008 | US20080026037 Compositions Comprising Strontium and Vitamin D and Uses Thereof |
| 01/31/2008 | US20080026035 Method Of Treating Atrophic Vaginitis |
| 01/31/2008 | US20080026034 Therapeutic agent elution control process |
| 01/31/2008 | US20080026031 Implantable polymeric device for sustained release of buprenorphine |
| 01/31/2008 | US20080026022 Process for the preparation of stable polymer concentrates |
| 01/31/2008 | US20080026020 Cosmetic composition combining a C-glycoside derivative and an associative polymer |
| 01/31/2008 | US20080026019 Antigreying agent for hair |
| 01/31/2008 | US20080026018 Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities |
| 01/31/2008 | US20080026014 Nasal Stick for the Application of Medicaments and Skin Care Substances |
| 01/31/2008 | US20080026013 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080026000 Nicotine hapten where nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization; preventing nicotine addiction |
| 01/31/2008 | US20080025997 Cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 01/31/2008 | US20080025996 Methods and Compositions Comprising Polycationic Compounds |
| 01/31/2008 | US20080025991 Use of Aromatase Inhibitors for Treatment of Ectopic Pregnancy |
| 01/31/2008 | US20080025987 Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix |
| 01/31/2008 | US20080025986 Methods of Treating Tnf-Mediated Disorders |
| 01/31/2008 | US20080025984 Combination Therapy Comprising Cloretazine |
| 01/31/2008 | US20080025973 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 01/31/2008 | US20080025972 Treating sex steriod responsive disorders |
| 01/31/2008 | US20080025970 Treatment of atherosclerosis |
| 01/31/2008 | US20080025969 Treatment of Neurodegenerative Diseases by the Use of Gpr49 |
| 01/31/2008 | US20080025968 Methods and Agents for Immune Modulation and Methods for Identifying Immune Modulators |
| 01/31/2008 | US20080025965 Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein levels |
| 01/31/2008 | US20080025963 Compositions and methods for the treatment of CNS injuries |
| 01/31/2008 | US20080025962 Remedy for Alzheimer's Disease |
| 01/31/2008 | US20080025959 Permeability of blood-brain barrier |
| 01/31/2008 | US20080025952 Methods for targeted deliver of genetic material to the liver |
| 01/31/2008 | US20080025951 Administering to an individual having acute liver disease or inflammatory skin disease a carrier and a specific polypeptide that contains signal peptide sequences and a transmembrane spanning domain |
| 01/31/2008 | US20080025950 Modified Macromolescules and Associated Methods of Synthesis and Use |
| 01/31/2008 | US20080025949 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives |
| 01/31/2008 | US20080025946 Interleukin 21 and tyrosine kinase inhibitor combination therapy |
| 01/31/2008 | US20080025945 treating hepatic fibrosis; liver cirrhosis; administering to a patient an effective low dose of IL-6, a mutein, fused protein, active fraction or circularly permutated derivative |
| 01/31/2008 | US20080025944 Combination Therapy for Immunostimulation |
| 01/31/2008 | US20080025940 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof |
| 01/31/2008 | US20080025932 Skin care compositions containing a sugar amine |
| 01/31/2008 | US20080025921 Conductance of Improperly Folded Proteins Through the Secretory Pathway And Related Methods For Treating Disease |
| 01/31/2008 | US20080025920 Methods of treating hot flashes with formulations for transdermal or transmucosal application |
| 01/31/2008 | US20080025919 Benzoylguanidine salt and hydrates thereof |
| 01/31/2008 | US20080025917 Methods for modulating formation and progression of cellulite |
| 01/31/2008 | US20080025916 Tailored Treatment Suitable for Different Forms of Mastocytosis |
| 01/31/2008 | US20080023345 Packages for ophthalmic lenses containing pharmaceutical agents |
| 01/31/2008 | DE10261986B4 Hämokompatibel beschichtete Oberflächen, Verfahren zu deren Herstellung und deren Verwendungen Hemocompatibly coated surfaces, to processes for their preparation and their uses |
| 01/31/2008 | DE102006035789A1 Kosmetische Zubereitung umfassend Folsäure und Parfumbestandteile Cosmetic composition comprising folic acid and perfume ingredients |
| 01/31/2008 | DE102006035040A1 Active agent combination, useful to e.g. protect the skin against: skin aging and photoreaction, comprises ascorbic acid or ascorbyl compound; and mixture of alcohol, hydrogenated lecithin and palmitic acid |
| 01/31/2008 | DE102006034883A1 Composition, useful to treat inflammatory skin disease, e.g. psoriasis, comprises mometasone furoate, water, a combination of aromatic alcohol and a solvent e.g. alkoxylated fatty-alcohol and/or aliphatic alcohol, and further additives |
| 01/31/2008 | DE102006034256A1 Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidinfunktion in Arzneimitteln Improve the bioavailability of drugs with amidine in drugs |
| 01/31/2008 | DE102006033837A1 Konzentrierte Methotrexat-Lösungen Concentrated methotrexate solutions |
| 01/31/2008 | DE102006033109A1 Substituierte Heteroaryl-Derivate Substituted heteroaryl derivatives |
| 01/31/2008 | CA2694691A1 Drug combination pharmaceutical compositions and methods for using them |
| 01/31/2008 | CA2692256A1 Trauma therapy |
| 01/31/2008 | CA2672267A1 Arylsulfanyl compounds and compositions for delivering active agents |
| 01/31/2008 | CA2659605A1 Inhibitors of undecaprenyl pyrophosphate synthase |
| 01/31/2008 | CA2659353A1 Composition and method for treatment of tumors |
| 01/31/2008 | CA2659322A1 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | CA2659307A1 Crystalline erlotinib |
| 01/31/2008 | CA2659262A1 Improved vaccines and methods for using the same |
| 01/31/2008 | CA2659259A1 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | CA2659253A1 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | CA2659242A1 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 01/31/2008 | CA2659211A1 Methods for treating and preventing mucositis |
| 01/31/2008 | CA2659192A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | CA2659055A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 01/31/2008 | CA2659050A1 Camptothecin derivatives with antitumor activity |
| 01/31/2008 | CA2658923A1 Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes |
| 01/31/2008 | CA2658921A1 Fused ring spiroketal derivative and use thereof as anti-diabetic drug |
| 01/31/2008 | CA2658917A1 3'-ethynylcytidine derivative |
| 01/31/2008 | CA2658913A1 Substituted aniline derivatives |
| 01/31/2008 | CA2658902A1 Camptothecin derivatives with antitumor activity |
| 01/31/2008 | CA2658900A1 Camptothecin derivatives with antitumor activity |
| 01/31/2008 | CA2658896A1 Crystalline forms of rapamycin analogs |
| 01/31/2008 | CA2658887A1 Fatty acid amide hydrolase inhibitors |
| 01/31/2008 | CA2658881A1 Methods for treating acute acoustic trauma |
| 01/31/2008 | CA2658877A1 Heme oxygenase inhibitors for the treatment of a microbial infection |
| 01/31/2008 | CA2658821A1 Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors |
| 01/31/2008 | CA2658804A1 Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi |
| 01/31/2008 | CA2658782A1 Compounds and compositions as hedgehog pathway modulators |
| 01/31/2008 | CA2658632A1 Method for prevention and treatment of alzheimers |
| 01/31/2008 | CA2658629A1 Chewable tablet containing phenylephrine |
| 01/31/2008 | CA2658627A1 Imidazothiazole derivatives as mark inhibitors |
| 01/31/2008 | CA2658625A1 Substituted imidazolone derivatives, preparation and uses |
| 01/31/2008 | CA2658624A1 Pyridazine and pyrrole compounds, processes for obtaining them and applications thereof |
| 01/31/2008 | CA2658558A1 Inhibitors of undecaprenyl pyrophosphate synthase |
| 01/31/2008 | CA2658534A1 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 01/31/2008 | CA2658496A1 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-yl} acetic acid derivatives and esters thereof having crth2 antagonist activity |
| 01/31/2008 | CA2658493A1 Pharmaceutical formulation comprising donepezil |
| 01/31/2008 | CA2658436A1 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 01/31/2008 | CA2658246A1 Monoamine oxidase inhibitors useful for treating disorders of the outer retina |
| 01/31/2008 | CA2658245A1 Systems and methods to treat pain locally |
| 01/31/2008 | CA2658058A1 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 01/31/2008 | CA2658037A1 Prodrug of cinnamide compound |
| 01/31/2008 | CA2657815A1 Annellated pyrrole compounds for cancer management |
| 01/31/2008 | CA2657718A1 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing |
| 01/31/2008 | CA2657706A1 Dimeric iap antagonists |
| 01/31/2008 | CA2657566A1 Pyrazoles as glucokinase activators |
| 01/31/2008 | CA2657480A1 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 01/31/2008 | CA2657238A1 Compositions and methods for treating or preventing ophthalmic disease |
| 01/31/2008 | CA2657202A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 01/31/2008 | CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | CA2657164A1 Compositions and methods for treating or preventing ophthalmic light toxicity |